Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062005
Filing Date
2019-11-12
Accepted
2019-11-12 07:01:24
Documents
44
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919563d1_10q.htm 10-Q 450085
2 EXHIBIT 31.1 tm1919563d1_ex31-1.htm EX-31.1 8623
3 EXHIBIT 31.2 tm1919563d1_ex31-2.htm EX-31.2 8438
4 EXHIBIT 32.1 tm1919563d1_ex32-1.htm EX-32.1 3711
5 EXHIBIT 32.2 tm1919563d1_ex32-2.htm EX-32.2 3636
12 GRAPHIC tm1919563d1_img001.jpg GRAPHIC 18279
  Complete submission text file 0001104659-19-062005.txt   2397416

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ntrp-20190930.xml EX-101.INS 356205
7 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20190930.xsd EX-101.SCH 29675
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntrp-20190930_cal.xml EX-101.CAL 22452
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntrp-20190930_def.xml EX-101.DEF 99531
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20190930_lab.xml EX-101.LAB 228615
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20190930_pre.xml EX-101.PRE 197351
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

EIN.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38045 | Film No.: 191205992
SIC: 2834 Pharmaceutical Preparations